AT422671T - A method for diagnosis of Alzheimer's disease - Google Patents

A method for diagnosis of Alzheimer's disease

Info

Publication number
AT422671T
AT422671T AT03771762T AT03771762T AT422671T AT 422671 T AT422671 T AT 422671T AT 03771762 T AT03771762 T AT 03771762T AT 03771762 T AT03771762 T AT 03771762T AT 422671 T AT422671 T AT 422671T
Authority
AT
Austria
Prior art keywords
alzheimer
diagnosis
disease
method
Prior art date
Application number
AT03771762T
Other languages
German (de)
Inventor
Yadong Huang
Original Assignee
David Gladstone Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US40001602P priority Critical
Application filed by David Gladstone Inst filed Critical David Gladstone Inst
Publication of AT422671T publication Critical patent/AT422671T/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/2814Dementia; Cognitive disorders
    • G01N2800/2821Alzheimer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment; Prognosis
AT03771762T 2002-07-30 2003-07-24 A method for diagnosis of Alzheimer's disease AT422671T (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US40001602P true 2002-07-30 2002-07-30

Publications (1)

Publication Number Publication Date
AT422671T true AT422671T (en) 2009-02-15

Family

ID=31188657

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03771762T AT422671T (en) 2002-07-30 2003-07-24 A method for diagnosis of Alzheimer's disease

Country Status (6)

Country Link
US (1) US7682795B2 (en)
EP (1) EP1543331B1 (en)
AT (1) AT422671T (en)
AU (1) AU2003259222A1 (en)
DE (1) DE60326153D1 (en)
WO (1) WO2004011943A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10303974A1 (en) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β (1-42) oligomers, processes for their preparation and their use
US7612179B2 (en) 2003-11-28 2009-11-03 Astrazeneca Ab antibodies binding to a C-terminal fragment of apoliopoprotein E
AU2004293180B2 (en) * 2003-11-28 2011-09-15 Astrazeneca Ab Antibodies binding to a C-terminal fragment of Apolipoprotein E
WO2006110621A2 (en) * 2005-04-11 2006-10-19 Cornell Research Foundation, Inc. Multiplexed biomarkers for monitoring the alzheimer's disease state of a subject
AU2006320392B2 (en) 2005-11-30 2013-01-17 AbbVie Deutschland GmbH & Co. KG Monoclonal antibodies against amyloid beta protein and uses thereof
PT1954718E (en) 2005-11-30 2014-12-16 Abbvie Inc Anti-a globulomer antibodies, antigen-binding moieties thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods of producing said antibodies, compositions comprising said antibodies, uses of said antibodies and methods of using said antibodies
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
US20090136456A1 (en) * 2006-12-22 2009-05-28 Yadong Huang Methods of treating neurodegenerative disorders
US8895004B2 (en) 2007-02-27 2014-11-25 AbbVie Deutschland GmbH & Co. KG Method for the treatment of amyloidoses
WO2009062152A1 (en) * 2007-11-09 2009-05-14 Washington University In St. Louis Methods for measuring the metabolism of cns derived biomolecules in vivo
US9102717B2 (en) * 2010-03-01 2015-08-11 The J. David Gladstone Institutes Antibody specific for apolipoprotein and methods of use thereof
CA2796339A1 (en) 2010-04-15 2011-10-20 Abbott Laboratories Amyloid-beta binding proteins
MX358739B (en) 2010-08-14 2018-09-03 Abbvie Inc Star Amyloid-beta binding proteins.
US9488666B2 (en) 2010-08-24 2016-11-08 Helena Laboratories Corporation Assay for determination of levels of lipoprotein particles in bodily fluids
CA2825791A1 (en) 2011-02-07 2012-08-16 Neotope Biosciences Limited Apoe immunotherapy

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811310A (en) * 1986-09-30 1998-09-22 Albert Einstein College Of Medicine Of Yeshiva Univ. The Alz-50 monoclonal antibody and diagnostic assay for alzheimer's disease
US6287793B1 (en) * 1988-08-19 2001-09-11 Elan Pharmaceuticals, Inc. Diagnostic methods for alzheimer's disease
WO1993003369A1 (en) * 1991-08-01 1993-02-18 Voorheis Paul H Diagnostic method for alzheimer's disease
CA2086165A1 (en) * 1992-04-09 1993-10-10 Paul P. Tamburini Diagnostic assay for alzheimer's disease based on the proteolysis of alzheimer's precursor protein
WO1994009371A1 (en) * 1992-10-09 1994-04-28 Massachusetts Institute Of Technology Antemortem diagnostic test for alzheimer's disease
DE69333461T2 (en) * 1992-10-13 2005-03-24 Duke University METHOD FOR evidence of Alzheimer's disease
US6300085B1 (en) * 1993-05-03 2001-10-09 The United States Of America As Represented By The Department Of Health And Human Services Diagnostic method for Alzheimer's disease
US5849600A (en) * 1993-11-10 1998-12-15 The Mclean Hospital Corporation Diagnostic assays for Alzheimer's disease
FR2716894B1 (en) * 1994-03-07 1996-05-24 Pasteur Institut Genetic markers used together for the diagnosis of Alzheimer's disease, method and diagnostic kit.
US5976798A (en) * 1994-03-30 1999-11-02 Mitokor Methods for detecting mitochondrial mutations diagnostic for Alzheimer's disease and methods for determining heteroplasmy of mitochondrial nucleic acid
US5972634A (en) * 1994-10-19 1999-10-26 The General Hospital Corporation Diagnostic assay for Alzheimer's disease: assessment of Aβ abnormalities
US5817789A (en) * 1995-06-06 1998-10-06 Transkaryotic Therapies, Inc. Chimeric proteins for use in transport of a selected substance into cells
US5976817A (en) * 1996-10-31 1999-11-02 Trustees Of Boston University Diagnostic method for detecting Alzheimer's disease in living patients
US6183981B1 (en) * 1998-03-05 2001-02-06 Board Of Regents, The University Of Texas System Diagnostic assay for late-onset Alzheimer's disease
CA2426030C (en) * 2000-11-03 2013-12-31 The J. David Gladstone Institutes Methods of treating disorders related to apoe
US6766817B2 (en) * 2001-07-25 2004-07-27 Tubarc Technologies, Llc Fluid conduction utilizing a reversible unsaturated siphon with tubarc porosity action

Also Published As

Publication number Publication date
US20040157267A1 (en) 2004-08-12
WO2004011943A1 (en) 2004-02-05
EP1543331A4 (en) 2006-08-02
DE60326153D1 (en) 2009-03-26
US7682795B2 (en) 2010-03-23
EP1543331B1 (en) 2009-02-11
AU2003259222A1 (en) 2004-02-16
EP1543331A1 (en) 2005-06-22

Similar Documents

Publication Publication Date Title
DE60334505D1 (en) A method for extracting direct mode motion vectors
DE60133278D1 (en) A device for treatment of heart disease
DE50309009D1 (en) A process for producing a three-
DE60207848D1 (en) A process for the preparation of concentrated human immunoglobulins for therapeutic use
AT412003T (en) Methods for diagnosis of alzheimer's disease on the basis of a gen transcriptional pattern
DE60327351D1 (en) A process for preparing polyalklyencarbonaten
DE60228310D1 (en) A method for non-invasive investigation of bones
AT412972T (en) A process for preparing vertikalstruktur- leds
DE60330917D1 (en) A method for producing a catheter
DE60308596D1 (en) A process for producing nanotubes anorganisichen
DE50212650D1 (en) A process for preparing scopinestern
DE60329177D1 (en) A process for preparing Tansistoren
DE60202373D1 (en) A process for producing lithium titanate
DE60016178D1 (en) A method for the diagnosis and characterization of stroke
DE69921826D1 (en) A device for treatment of heart disease
DE60328659D1 (en) A process for preparing molekularsiebadsorbensmischungen
DE60317660D1 (en) A process for the preparation of polyester
AT230487T (en) Method for the early diagnosis of carcinomas
DE69535214D1 (en) A method for diagnosis of glaucoma
DE60010309D1 (en) A method for real-time display of medical images
AT299945T (en) A method for producing L-amino acids
AT549381T (en) A method for preparing modified pigments
AT340819T (en) A process for the preparation of polyamides
DE60328590D1 (en) System and method for determining a patient's disease
AT290903T (en) A device for diagnosis of sleep apnea

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties